Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.13%
#3 CoW Protocol CoW Protocol +37.72%
#4 Glidr Glidr +36.87%
#5 RedStone RedStone +30.25%
#6 Humanity Humanity +24.45%
#7 Codatta Codatta +21.34%
#8 The Black Bull The Black Bull +19.65%
#9 Walrus Walrus +19.14%
#10 Tutorial Tutorial +19.10%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR
Classement en actions #36561
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Prix de l'action
$1.73
Dernière synchronisation: 2025-06-17
Capitalisation boursière
$2.55M
Changement (1 jour)
-0.29%
Changement (1 an)
0.00%
Pays
US
Échange Eiger BioPharmaceuticals, Inc. (EIGR)

Catégorie

Healthcare
Historique du prix de l'action pour Eiger BioPharmaceuticals, Inc. (EIGR)
Prix de clôture le plus élevé : $1.73 le 2025-06-01

Prix de clôture le plus bas : $3.75K le 2014-01-01
Historique du prix de l'action de Eiger BioPharmaceuticals, Inc. de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -31.11%
2024 -68.15%
2023 -86.27%
2022 -65.86%
2021 -43.34%
2020 -27.82%
2019 28.55%
2018 -15.78%
2017 8.44%
2016 -45.90%
2015 -91.44%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE